SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Dwight D. Eisenhower — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientDwight D. Eisenhower
Date of birth1890-10-14
IdentifiersMRN HR-ET015-SYN-TD; SSN (made up) 000-15-2673
Document date1956-05-11
AuthorRussell Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Seven-month coronary disease review. [S]

History of Present Illness

Mr. Eisenhower returns for his seven-month review. He works full time, travels most weeks, and plays golf twice a week, walking the course, without chest pain or breathlessness. The right-sided nosebleed four weeks ago has not recurred after cautery, and he stopped the petroleum jelly after two weeks. He continues every dose of aspirin and ticagrelor. His home blood pressure averages 120/74 and he has lost 1.5 kg since January. [S]

ElementDetail
Interval changeFull activity including golf; no angina
NosebleedNo recurrence since cautery four weeks ago
Home blood pressureAverage 120/74
WeightDown 1.5 kg since January
Nitroglycerin useNone

Review of Systems

SystemResultFinding
ConstitutionalNegativeGood energy; intentional weight loss
Ears, nose, mouth, and throatNegativeNo further nosebleeds
CardiovascularNegativeNo chest pain, palpitations, or edema
RespiratoryNegativeNo breathlessness walking the golf course
PsychiatricNegativeMood good; PHQ-2 score 0

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-24activeS
Ticagrelor 90 mg oral tablet, one tablet by mouth twice dailyOne tablet by mouth twice dailyOral route1955-09-24 to 1956-09-28completedS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-24activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-25activeS
Lisinopril 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-26 to 1956-01-12completedS
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1956-01-12activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1956-01-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route1955-09-24activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1956-05-11Body height178cmS
1956-05-11Body weight77.4kgS
1956-05-11Body mass index (BMI) [Ratio]24.4kg/m2S
1956-05-11Systolic blood pressure122mm[Hg]S
1956-05-11Diastolic blood pressure74mm[Hg]S
1956-05-11Heart rate58/minS
1956-05-11Respiratory rate14/minS
1956-05-11Body temperature36.6CelS
1956-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1956-05-11Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 1956-05-11; see the Vital Signs section. [S]

SystemFinding
GeneralWell, tanned from golf
NoseRight anterior septum healed
HeartRegular rhythm; no murmur or gallop
LungsClear
ExtremitiesNo edema

Problems

ProblemClinical statusVerificationCodeProvenance
Anterior ST-elevation myocardial infarction about four months before intake, treated with a drug-eluting stent to the left anterior descending artery; synthetic modern episode linked to the documented 1885 anterolateral infarctionactiveconfirmed I25.2S — Synthetic modern diagnosis; the 1955 infarction remains D in the history.
Coronary artery disease, single-vessel, after stenting; no anginaactiveconfirmed I25.10S — Synthetic diagnosis supporting secondary prevention.
Hyperlipidemia, on high-intensity statinactiveconfirmed E78.5S — Synthetic diagnosis; no cholesterol value from his lifetime is used.
Essential hypertensionactiveconfirmed I10S — Synthetic diagnosis; no blood pressure from his lifetime is used.
Former heavy cigarette smoker, quit about seven years before intakeactiveconfirmed Z87.891S — Synthetic coded history echoing the documented heavy smoking and quitting around 1949.
Anterior epistaxis, right side, on dual antiplatelet therapy; controlled with silver nitrate cauteryresolvedconfirmed R04.0S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure, heart rate, weight and BMI, heart and lungs, edemaEvery visitCompleted todayBlood pressure 122/74 mmHg, weight 77.4 kg, BMI 24.4
Medication safetyDual antiplatelet therapy adherence and bleedingEvery visitCompleted todayTaking all doses; one anterior nosebleed four weeks ago, controlled with cautery, without recurrence
Medication safetyStatin, beta-blocker, and ACE inhibitor adherenceEvery visitCompleted todayTaking all doses
LaboratoryBasic metabolic panel1 to 2 weeks after starting or changing an ACE inhibitor, then every 6 monthsDueDue in July; order given to draw before the one-year review
LaboratoryLipid panel4 to 12 weeks after starting or changing therapy, then every 3 to 12 monthsUp to dateLDL cholesterol 50 mg/dL in March; next at the one-year review
SurveyDepression screen (PHQ-2)Every visitCompleted todayScore 0
Self-managementTobacco useEvery visitCompleted todayAbstinent
Self-managementPhysical activity and dietEvery visitCompleted todayGolf twice a week walking the course; brisk walks on other days
ExaminationClinical follow-up visitEvery 4 to 6 months in the first yearCompleted todayNext at one year, when the antiplatelet plan changes

Goal progress:

Guideline basis: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, acute myocardial infarction, ischemic heart disease, hyperlipidemia, and hypertension monographs (2026)

Follow-up: One-year review in about four and a half months, with a lipid panel and basic metabolic panel. Next scheduled visit 1956-09-28: one-year review after myocardial infarction: end of dual antiplatelet therapy. [S]